• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性硬化性胆管炎患者的炎症性肠病表型在结肠炎的分布上有所不同。

The phenotypic expression of inflammatory bowel disease in patients with primary sclerosing cholangitis differs in the distribution of colitis.

机构信息

Department of Laboratory Medicine and Pathology, Toronto General Hospital, University of Toronto, 200 Elizabeth Street, Toronto, ON, M5G 2C4, Canada.

出版信息

Dig Dis Sci. 2013 Sep;58(9):2608-14. doi: 10.1007/s10620-013-2697-7. Epub 2013 May 14.

DOI:10.1007/s10620-013-2697-7
PMID:23670229
Abstract

BACKGROUND

Inflammatory bowel disease (IBD) associated with primary sclerosing cholangitis (PSC) is reported to be mild and prone to right-side predominance with rectal sparing. However, no dedicated studies evaluating patterns of presentation of liver disease with respect to IBD are available.

METHODS

We performed a detailed histological examination of the colonic biopsies in the context of PSC, identifying 97 patients [89 with ulcerative colitis and ten with Crohn's disease (CD)] stratified into two groups, based on their initial disease presentation: hepatic/biliary (group 1-PSC-IBD; n=56) versus colonic (group 2-IBD-PSC; n=41).

RESULTS

Inflammatory bowel disease that preceded PSC had a tendency to have a "pan-colitis" distribution; this group included all patients with CD. Inflammatory bowel disease diagnosis that followed PSC presentation was more likely to be right-sided, sparing the descending, sigmoid and rectal regions (p=0.002). In both groups, colitis was mild with focal deep plasmacytosis and occasional mild cryptitis. Active cryptitis with crypt abscesses, surface erosion and ulceration were not identified in any of the patients.

CONCLUSION

Colitis associated with PSC shows mild disease activity and the colitis pattern is associated with disease presentation, i.e. colitis preceding PSC (IBD-PSC cohort) typically have a pancolitic distribution, while colitis following PSC (PSC-IBD cohort) demonstrates right-sided predominance. Awareness by pathologists and clinicians of these patterns of inflammatory bowel disease is important and of use in directing appropriate investigations for patients.

摘要

背景

据报道,与原发性硬化性胆管炎(PSC)相关的炎症性肠病(IBD)较轻,且易于右半结肠受累而直肠不受累。然而,目前尚无专门研究评估 IBD 患者肝脏疾病表现模式。

方法

我们对 PSC 患者的结肠活检标本进行了详细的组织学检查,确定了 97 例患者[89 例溃疡性结肠炎和 10 例克罗恩病(CD)],根据其初始疾病表现分为两组:肝/胆(PSC-IBD 组,n=56)和结肠(IBD-PSC 组,n=41)。

结果

IBD 先于 PSC 出现时倾向于呈“全结肠炎”分布,这组包括所有 CD 患者。PSC 后出现的 IBD 更可能为右半结肠受累,降结肠、乙状结肠和直肠不受累(p=0.002)。在两组中,结肠炎均为轻度,表现为局灶性浆细胞浸润和偶尔轻度隐窝炎。任何患者均未发现活动性隐窝炎伴隐窝脓肿、黏膜表面糜烂和溃疡。

结论

PSC 相关结肠炎活动度较轻,且结肠炎的分布与疾病表现相关,即先于 PSC 的结肠炎(IBD-PSC 组)通常呈全结肠炎分布,而继于 PSC 的结肠炎(PSC-IBD 组)则表现为右半结肠优势分布。病理科医生和临床医生了解这些 IBD 表现模式很重要,有助于指导对患者进行适当的检查。

相似文献

1
The phenotypic expression of inflammatory bowel disease in patients with primary sclerosing cholangitis differs in the distribution of colitis.原发性硬化性胆管炎患者的炎症性肠病表型在结肠炎的分布上有所不同。
Dig Dis Sci. 2013 Sep;58(9):2608-14. doi: 10.1007/s10620-013-2697-7. Epub 2013 May 14.
2
Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease.原发性硬化性胆管炎与炎症性肠病的独特表型相关。
Inflamm Bowel Dis. 2012 Dec;18(12):2270-6. doi: 10.1002/ibd.22938. Epub 2012 Mar 8.
3
Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients.原发性硬化性胆管炎患者的炎症性肠病:肝移植和未肝移植患者的临床特征。
Inflamm Bowel Dis. 2012 Mar;18(3):536-45. doi: 10.1002/ibd.21699. Epub 2011 Mar 31.
4
Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis.原发性硬化性胆管炎和自身免疫性硬化性胆管炎中慢性炎症性肠病的对比模式
EBioMedicine. 2015 Sep 2;2(10):1523-7. doi: 10.1016/j.ebiom.2015.08.041. eCollection 2015 Oct.
5
Symptoms Do Not Correlate With Findings From Colonoscopy in Children With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.炎症性肠病和原发性硬化性胆管炎患儿的症状与结肠镜检查结果不相关。
Clin Gastroenterol Hepatol. 2018 Jul;16(7):1098-1105.e1. doi: 10.1016/j.cgh.2018.01.020. Epub 2018 Mar 24.
6
Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis.原发性硬化性胆管炎相关炎症性肠病的临床特征。
J Hepatobiliary Pancreat Sci. 2011 Mar;18(2):154-61. doi: 10.1007/s00534-010-0319-8.
7
Inflammatory bowel disease of primary sclerosing cholangitis: a distinct entity?原发性硬化性胆管炎的炎症性肠病:一种独特的疾病实体?
World J Gastroenterol. 2014 Mar 28;20(12):3245-54. doi: 10.3748/wjg.v20.i12.3245.
8
Primary sclerosing cholangitis and disease distribution in inflammatory bowel disease.原发性硬化性胆管炎与炎症性肠病的疾病分布。
Clin Gastroenterol Hepatol. 2012 Apr;10(4):439-41. doi: 10.1016/j.cgh.2011.11.010. Epub 2011 Nov 15.
9
Outcome of Very Early Onset Inflammatory Bowel Disease Associated With Primary Sclerosing Cholangitis: A Multicenter Study From the Pediatric IBD Porto Group of ESPGHAN.原发性硬化性胆管炎相关的极早发性炎症性肠病的结局:来自 ESPGHAN 的儿科 IBD 波尔图小组的一项多中心研究。
Inflamm Bowel Dis. 2024 Oct 3;30(10):1662-1669. doi: 10.1093/ibd/izad218.
10
Increased Risk of Non-conventional and Invisible Dysplasias in Patients with Primary Sclerosing Cholangitis and Inflammatory Bowel Disease.原发性硬化性胆管炎和炎症性肠病患者发生非传统型和隐匿性发育异常的风险增加。
J Crohns Colitis. 2022 Dec 5;16(12):1825-1834. doi: 10.1093/ecco-jcc/jjac090.

引用本文的文献

1
All you need to know about the overlap between primary sclerosing cholangitis and inflammatory bowel disease.关于原发性硬化性胆管炎与炎症性肠病重叠的所有你需要了解的信息。
Ann Gastroenterol. 2025 Mar-Apr;38(2):107-120. doi: 10.20524/aog.2025.0945. Epub 2025 Feb 25.
2
Unique clinical, morphological, and molecular characteristics of tumors associated with PSC-IBD.与原发性硬化性胆管炎-炎症性肠病相关的肿瘤的独特临床、形态学和分子特征。
Virchows Arch. 2025 Apr;486(4):651-661. doi: 10.1007/s00428-025-04072-y. Epub 2025 Mar 19.
3
Intestinal histopathology in pediatric PSC-IBD: Characterization of phenotype and assessment of the Nancy Index.

本文引用的文献

1
Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease.原发性硬化性胆管炎与炎症性肠病的独特表型相关。
Inflamm Bowel Dis. 2012 Dec;18(12):2270-6. doi: 10.1002/ibd.22938. Epub 2012 Mar 8.
2
High dose ursodeoxycholic acid in primary sclerosing cholangitis does not prevent colorectal neoplasia.大剂量熊去氧胆酸治疗原发性硬化性胆管炎不能预防结直肠肿瘤。
Aliment Pharmacol Ther. 2012 Feb;35(4):451-7. doi: 10.1111/j.1365-2036.2011.04966.x. Epub 2012 Jan 5.
3
Genetics in primary sclerosing cholangitis.
儿童原发性硬化性胆管炎-炎症性肠病的肠道组织病理学:表型特征及南希指数评估
J Pediatr Gastroenterol Nutr. 2025 Feb;80(2):290-299. doi: 10.1002/jpn3.12434. Epub 2024 Dec 17.
4
Concurrent inflammatory bowel disease and primary sclerosing cholangitis: a review of pre- and post-transplant outcomes and treatment options.炎症性肠病与原发性硬化性胆管炎并存:移植前后结局及治疗选择综述
Gastroenterol Hepatol Bed Bench. 2023;16(3):259-269. doi: 10.22037/ghfbb.v16i2.2589.
5
Treatment of primary sclerosing cholangitis combined with inflammatory bowel disease.原发性硬化性胆管炎合并炎症性肠病的治疗
Intest Res. 2023 Oct;21(4):420-432. doi: 10.5217/ir.2023.00039. Epub 2023 Sep 1.
6
Primary sclerosing cholangitis (PSC) and inflammatory bowel disease (IBD): a condition exemplifying the crosstalk of the gut-liver axis.原发性硬化性胆管炎 (PSC) 和炎症性肠病 (IBD):一种体现肠道-肝脏轴相互作用的病症。
Exp Mol Med. 2023 Jul;55(7):1380-1387. doi: 10.1038/s12276-023-01042-9. Epub 2023 Jul 18.
7
A Current State of Proteomics in Adult and Pediatric Inflammatory Bowel Diseases: A Systematic Search and Review.蛋白质组学在成人和儿童炎症性肠病中的现状:系统检索和综述。
Int J Mol Sci. 2023 May 27;24(11):9386. doi: 10.3390/ijms24119386.
8
Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders.炎症性肠病的肝脏方面:肝胆及药物性疾病。
World J Hepatol. 2021 Dec 27;13(12):1828-1849. doi: 10.4254/wjh.v13.i12.1828.
9
Primary Sclerosing Cholangitis, Part 1: Epidemiology, Etiopathogenesis, Clinical Features, and Treatment.原发性硬化性胆管炎,第1部分:流行病学、病因发病机制、临床特征及治疗
Gastroenterol Hepatol (N Y). 2018 May;14(5):293-304.
10
The IBD and PSC Phenotypes of PSC-IBD.原发性硬化性胆管炎-炎症性肠病的炎症性肠病和原发性硬化性胆管炎表型
Curr Gastroenterol Rep. 2018 Mar 28;20(4):16. doi: 10.1007/s11894-018-0620-2.
原发性硬化性胆管炎的遗传学。
Best Pract Res Clin Gastroenterol. 2011 Dec;25(6):713-26. doi: 10.1016/j.bpg.2011.09.010.
4
Current consensus on the management of primary sclerosing cholangitis.原发性硬化性胆管炎的治疗共识。
Clin Res Hepatol Gastroenterol. 2011 Dec;35(12):786-91. doi: 10.1016/j.clinre.2011.04.007. Epub 2011 Oct 1.
5
Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis.原发性硬化性胆管炎相关炎症性肠病的临床特征。
J Hepatobiliary Pancreat Sci. 2011 Mar;18(2):154-61. doi: 10.1007/s00534-010-0319-8.
6
Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study.原发性硬化性胆管炎患者溃疡性结肠炎的病理特征:一项病例对照研究。
Am J Surg Pathol. 2009 Jun;33(6):854-62. doi: 10.1097/PAS.0b013e318196d018.
7
Clinical course of ulcerative colitis in patients with and without primary sclerosing cholangitis.患有和未患有原发性硬化性胆管炎的溃疡性结肠炎患者的临床病程。
J Gastroenterol Hepatol. 2005 Mar;20(3):366-70. doi: 10.1111/j.1440-1746.2005.03727.x.
8
PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis.原发性硬化性胆管炎相关的炎症性肠病:一种独特的炎症性肠病形式。
Gut. 2005 Jan;54(1):91-6. doi: 10.1136/gut.2004.046615.
9
Analysis of 388 cases of primary sclerosing cholangitis in Japan; Presence of a subgroup without pancreatic involvement in older patients.日本388例原发性硬化性胆管炎病例分析;老年患者中存在无胰腺受累的亚组。
Hepatol Res. 2004 Jul;29(3):153-159. doi: 10.1016/j.hepres.2004.03.006.
10
SCLEROSING CHOLANGITIS; REVIEW OF RECENT CASE REPORTS AND ASSOCIATED DISEASES AND FOUR NEW CASES.硬化性胆管炎;近期病例报告及相关疾病综述与4例新病例
Am J Surg. 1965 Aug;110:239-46. doi: 10.1016/0002-9610(65)90018-8.